Magnetically Responsive Polymeric Microparticles for Oral Delivery of Protein Drugs
暂无分享,去创建一个
Ali Khademhosseini | Jianjun Cheng | Omid C. Farokhzad | A. Khademhosseini | R. Langer | O. Farokhzad | Jianjun Cheng | S. Jon | Benjamin A. Teply | I. Sherifi | Sangyong Jon | Robert S. Langer | S. Jeong | Ines Sherifi | Seok Yoon Jeong | Christopher H. Yim | Dennis Ho | D. Ho
[1] Samir Mitragotri,et al. Oral delivery of macromolecules using intestinal patches: applications for insulin delivery. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[2] E. Mathiowitz,et al. Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[3] M. Kisel,et al. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. , 2001, International journal of pharmaceutics.
[4] A. Fasano,et al. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. , 1997, The Journal of clinical investigation.
[5] J. Irache,et al. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.
[6] T. Kararli. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.
[7] G. Hardee,et al. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[8] R. Langer,et al. Polymerized liposomes as potential oral vaccine carriers: Stability and bioavailability , 1996 .
[9] U. Häfeli,et al. Magnetically modulated therapeutic systems. , 2004, International journal of pharmaceutics.
[10] H. Ahlman,et al. A comparison of small intestinal transit time between the rat and the guinea-pig. , 1976, Acta chirurgica Scandinavica.
[11] Akira Yamamoto,et al. Effects of Various Protease Inhibitors on the Intestinal Absorption and Degradation of Insulin in Rats , 1994, Pharmaceutical Research.
[12] Donald E. Chickering,et al. Biologically erodable microspheres as potential oral drug delivery systems , 1997, Nature.
[13] S. Yamashita,et al. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. , 1999, Journal of pharmaceutical sciences.
[14] C. N. Ramchand,et al. Direct binding of protein to magnetic particles , 1997 .
[15] Robert Langer,et al. Magnetically-Responsive Polymerized Liposomes as Potential Oral Delivery Vehicles , 1997, Pharmaceutical Research.
[16] S. W. Kim,et al. Stabilization of insulin by alkylmaltosides. B. Oral absorption in vivo in rats , 1996 .
[17] A. Yamamoto,et al. Effects of Different Absorption Enhancers on the Permeation of Ebiratide, an ACTH Analogue, across Intestinal Membranes , 1997, The Journal of pharmacy and pharmacology.
[18] N. Peppas,et al. Oral delivery of insulin using pH-responsive complexation gels. , 1999, Journal of pharmaceutical sciences.
[19] I. Gómez-Orellana,et al. Challenges for the oral delivery of macromolecules , 2003, Nature Reviews Drug Discovery.
[20] H. Junginger,et al. Effects of the Mucoadhesive Polymer Polycarbophil on the Intestinal Absorption of a Peptide Drug in the Rat , 1992, The Journal of pharmacy and pharmacology.
[21] T. Fujita,et al. Enhanced Permeability of Insulin across the Rat Intestinal Membrane by Various Absorption Enhancers: Their Intestinal Mucosal Toxicity and Absorption‐enhancing Mechanism of n‐Lauryl‐β‐D‐maltopyranoside , 1999, The Journal of pharmacy and pharmacology.